NASDAQ: IRON - Disc Medicine Opco Inc

半年間の収益性: +54.06%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Disc Medicine Opco Inc

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Disc Medicine Opco Inc

Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias, erythropoietic protoporphyria, and X-linked protoporphyria.

さらに詳しく
In addition, the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown, Massachusetts.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2020-08-12
ISIN US2546041011
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.discmedicine.com
Цена ао 60.3
1日あたりの価格変動: -2.17% (65.54)
週ごとの価格変動: -0.5891% (64.5)
月ごとの料金変更: -0.6662% (64.55)
3ヶ月間の価格変動: +28.06% (50.07)
半年間の価格変動: +54.06% (41.62)
年間の価格変動: +11.01% (57.76)
3年間の価格推移: +685.78% (8.16)
5年間の価格推移: 0% (64.12)
10年間の価格推移: 0% (64.12)
年初からの価格変動: -0.5891% (64.5)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 3.94 4
P/E 0 0
EV/EBITDA -11.02 0
合計: 2.5

効率

名前 意味 学年
ROA, % -20.77 0
ROE, % -22.15 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0231 10
合計: 8.6

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 170.1 10
収益性 EPS, % -87.32 0
合計: 5.8
さらに詳しく

機関 音量 共有, %
Atlas Venture Life Science Advisors, LLC 2745335 11.37
Orbimed Advisors LLC. 2269637 9.4
Bain Capital Life Sciences Investors, LLC 1332545 5.52
Adage Capital Partners GP L.L.C. 1308405 5.42
Paradigm Biocapital Advisors LP 1272279 5.27
Novo Holdings A/S 1090772 4.52
Perceptive Advisors LLC 895641 3.71
State Street Corporation 667301 2.76
Vanguard Group Inc 665452 2.76
Frazier Life Sciences Management, L.P. 655000 2.71

ETF 共有, % 年間の利益率, % 配当金, %
Virtus LifeSci Biotech Clinical Trials ETF 0.97272 63.04 0.33
iShares Micro-Cap ETF 0.2407 17.09 1.54048
Future Tech ETF 0.13875 426.34 0.8416
Principal Healthcare Innovators ETF 0.13875 618.5 0.8416
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.12922 18.2 1.66828
Invesco Nasdaq Biotechnology ETF 0.11589 28.58 0.8565
Direxion Daily S&P Biotech Bull 3x Shares 0.09631 4067.92 0.25924
Nuveen ESG Small-Cap ETF 0.08602 13.91 1.41019
ProShares Ultra Nasdaq Biotechnology 0.07817 51.7 0.85651
iShares ESG Aware MSCI USA Small-Cap ETF 0.0464 18.09 1.49366
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.03526 24.75 1.59225
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.02256 17.47 1.51433
ProShares UltraPro Russell2000 0.01709 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.01282 3 1.46057
iShares Morningstar Small-Cap ETF 0.01136 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01136 30.1 1.60498
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
iShares Russell 2000 Growth ETF 0.00769 38.04 0.6026
Avantis U.S Small Cap Equity ETF 0.00538 27.77 1.68271
ProShares Hedge Replication ETF 0.00471 5.92 1.47892
Humankind US Stock ETF 0.00322 18.81 1.99919
iShares Russell 3000 ETF 0.00174 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00156 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00026 30.98 1.40618
Dimensional U.S. Equity ETF 0.00013 31.53 1.3557
Avantis U.S. Equity ETF 0.00003 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817



スーパーバイザー 役職 支払い 生年
Dr. Donald William Nicholson Ph.D. Executive Chairman 164k 1958 (67 年)
Dr. John D. Quisel Esq., J.D., Ph.D. CEO, President & Director 750.12k 1971 (54 年)
Dr. William Jacob Savage M.D., Ph.D. Chief Medical Officer 687.74k 1974 (51 年)
Dr. Brian MacDonald ChB, MB, Ph.D. Founder & Chair of Scientific Advisory Board 88.54k 1960 (65 年)
Dr. Rahul Khara J.D., Pharm.D. General Counsel, Compliance Officer & Secretary N/A 1982 (43 年)
Mr. Srikanth Venkatraman Ph.D. Senior VP & Head of Chemistry N/A
Ms. Hua Yang Ph.D. Senior Vice President & Head of Early Development and Clinical Pharmacology N/A
Ms. Jean M. Franchi Chief Financial Officer N/A 1966 (59 年)
Mr. Jonathan Yu M.B.A. Chief Opearating Officer 539.32k 1981 (44 年)
Ms. Pamela Stephenson M.P.H. Chief Commercial Officer N/A 1968 (57 年)

住所: United States, Watertown. MA, 321 Arsenal Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.discmedicine.com